ESC 365 - Cardiac contractility modulation improves peak VO2, long-term survival and hospitalisations in heart failure with reduced ejection fraction; evidence from FIX-5C and the EU registry

HFA Premium Access

Cardiac contractility modulation improves peak VO2, long-term survival and hospitalisations in heart failure with reduced ejection fraction; evidence from FIX-5C and the EU registry

Session: Late breaking trial III - Innovative and device therapy

Topic: Treatment, Other

Speaker: Professor G. Hasenfuss (Goettingen, DE)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Gerd Hasenfuss

Georg-August University, Goettingen (Germany)

22 presentations

0 follower

11 more presentations in this session

Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II: a European Society of Cardiology survey of cardiac resynchronization therapy in 11.088 patients

Speaker: Professor C. Linde (Stockholm, SE)

Discussion - CRT Survey II

Long-term outcome in the pivotal MOMENTUM 3 trial: medical resource use and cost implications

Speaker: Professor M. Mehra (Boston, US)

Discussion - MOMENTUM 3

Discussion - FIX-5C and the EU registry

Access the full session

Late breaking trial III - Innovative and device therapy

Speakers: Professor G. Hasenfuss, Professor C. Linde, Professor M. Mehra

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources